ArticleOncology letters2022

Potential of a sphingosine 1-phosphate receptor antagonist and sphingosine kinase inhibitors as targets for multiple myeloma treatment.

Yuko Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.